Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 449

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Mutations in Regulatory Subunit Type 1A of Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase (PRKAR1A): Phenotype Analysis in 353 Patients and 80 Different Genotypes

Open access
Bertherat, Jérôme, Horvath, Anélia, Groussin, Lionel, Grabar, Sophie, Boikos, Sosipatros, Cazabat, Laure, Libe, Rosella, René-Corail, Fernande, Stergiopoulos, Sotirios, Bourdeau, Isabelle, Bei, Thalia, Clauser, Eric, Calender, Alain, Kirschner, Lawrence S., Bertagna, Xavier, Carney, J. Aidan, Stratakis, Constantine A. · 2009 · The Journal of Clinical Endocrinology & Metabolism

Abstract

BACKGROUND: The "complex of myxomas, spotty skin pigmentation, and endocrine overactivity," or "Carney complex" (CNC), is caused by inactivating mutations of the regulatory subunit type 1A of the cAMP-dependent protein kinase (PRKAR1A) gene and as yet unknown defect(s) in other gene(s). Delineation of a genotype-phenotype correlation for CNC patients is essential for understanding PRKAR1A function and providing counseling and preventive care. METHODS: A transatlantic consortium studied the molecular genotype and clinical phenotype of 353 patients (221 females and 132 males, age 34 +/- 19 yr) who carried a germline PRKAR1A mutation or were diagnosed with CNC and/or primary pigmented nodular adrenocortical disease. RESULTS: A total of 258 patients (73%) carried 80 different PRKAR1A mutations; 114 (62%) of the index cases had a PRKAR1A mutation. Most PRKAR1A mutations (82%) led to lack of detectable mutant protein (nonexpressed mutations) because of nonsense mRNA mediated decay. Patients with a PRKAR1A mutation were more likely to have pigmented skin lesions, myxomas, and thyroid and gonadal tumors; they also presented earlier with these tumors. Primary pigmented nodular adrenocortical disease occurred earlier, was more frequent in females, and was the only manifestation of CNC with a gender predilection. Mutations located in exons were more often associated with acromegaly, myxomas, lentigines, and schwannomas, whereas the frequent c.491-492delTG mutation was commonly associated with lentigines, cardiac myxomas, and thyroid tumors. Overall, nonexpressed PRKAR1A mutations were associated with less severe disease. CONCLUSION: CNC is genetically and clinically heterogeneous. Certain tumors are more frequent, with specific mutations providing some genotype-phenotype correlation for PRKAR1A mutations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2008-2333

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 4

  1. OMIM no. 160980. http://www.ncbi.nlm.nih.gov/omim/
  2. Conroy, 2004, Atrial myxoma: a cardiocutaneous syndrome., Hosp Med, 65, 56, 10.12968/hosp.2004.65.1.2423 · doi:10.12968/hosp.2004.65.1.2423
  3. Skamrov, 2003, [PRKAR1A gene mutations in two patients with myxoma syndrome (Carney complex)]., Kardiologiia, 43, 77
  4. Yoon, 2003, A typical Korean case of Carney complex., Korean J Intern Med, 18, 260, 10.3904/kjim.2003.18.4.260 · doi:10.3904/kjim.2003.18.4.260

Cited by

See all 449

Metadata

Authors
Bertherat, J., Horvath, A., Groussin, L., Grabar, S., Boikos, S., Cazabat, L., Libe, R., René-Corail, F., Stergiopoulos, S., Bourdeau, I., Bei, T., Clauser, E., Calender, A., Kirschner, L. S., Bertagna, X., Carney, J. A., & Stratakis, C. A.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2009-06-01
Volume
94
Issue
6
Pages
2085-2091
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2095849867
Cited by
449
References
35
FWCI
24.60
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.